Gene · 93
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1R206H -Specific Human Cellular and Zebrafish Models. | J Bone Miner Res | 2022 | 36153796 | PubTator, text mining | PubMed |
| Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension. | Front Genet | 2022 | 36147486 | PubTator, text mining | PubMed |
| In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes. | J Clin Med | 2022 | 36143003 | PubTator, text mining | PubMed |
| The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia. | Int J Mol Sci | 2022 | 36142738 | PubTator, text mining | PubMed |
| Could BMPs Therapy Be Improved if BMPs Were Used in Composition Acting during Bone Formation in Endochondral Ossification? | Int J Mol Sci | 2022 | 36142232 | PubTator, text mining | PubMed |
| Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries. | Genes (Basel) | 2022 | 36140829 | PubTator, text mining | PubMed |
| De novo disruptive heterozygous MMP21 variants are potential predisposing genetic risk factors in Chinese Han heterotaxy children. | Hum Genomics | 2022 | 36123719 | PubTator, text mining | PubMed |
| Muscle wasting in cancer: opportunities and challenges for exercise in clinical cancer trials. | JCSM Rapid Commun | 2022 | 36118249 | PubTator, text mining | PubMed |
| Low expression of INHB co-receptor TGFBR3 in connection with metastasis and immune infiltration in lung adenocarcinoma. | Am J Transl Res | 2022 | 36105051 | PubTator, text mining | PubMed |
| A multi-disciplinary, comprehensive approach to management of children with heterotaxy. | Orphanet J Rare Dis | 2022 | 36085154 | PubTator, text mining | PubMed |
| Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics. | Cells | 2022 | 36078078 | PubTator, text mining | PubMed |
| Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes. | Cancers (Basel) | 2022 | 36077789 | PubTator, text mining | PubMed |
| Fine-mapping and identification of candidate causal genes for tail length in the Merinolandschaf breed. | Commun Biol | 2022 | 36068271 | PubTator, text mining | PubMed |
| Endoglin and Systemic Sclerosis: A PRISMA-driven systematic review. | Front Med (Lausanne) | 2022 | 36059817 | PubTator, text mining | PubMed |
| Cyclosporine A Modulates LSP1 Protein Levels in Human B Cells to Attenuate B Cell Migration at Low O2 Levels. | Life (Basel) | 2022 | 36013463 | PubTator, text mining | PubMed |
| The Contribution of Genetics to Muscle Disuse, Retraining, and Aging. | Genes (Basel) | 2022 | 36011290 | PubTator, text mining | PubMed |
| Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration. | Cancers (Basel) | 2022 | 36011023 | PubTator, text mining | PubMed |
| Muscle and Bone Defects in Metastatic Disease. | Curr Osteoporos Rep | 2022 | 35994202 | PubTator, text mining | PubMed |
| Vasculogenesis in kidney organoids upon transplantation. | NPJ Regen Med | 2022 | 35986027 | PubTator, text mining | PubMed |
| What Role Do Inflammatory Cytokines Play in Cancer Cachexia? | Cureus | 2022 | 35971351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/93/papers?page=14